Ignite Creation Date:
2024-05-05 @ 5:03 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00378261
Status:
COMPLETED
Last Update Posted:
2011-05-19
First Post:
2006-09-15
Brief Title:
APART Advanced Profiling of Anti-Rheumatic Therapies
Sponsor:
Centocor Ortho Biotech Services LLC
Organization:
Centocor Ortho Biotech Services LLC
Study Overview
Official Title:
A Multicenter Randomized Open Study to Evaluate the Impact of an Electronic Data Capture System on the Care of Patients With Rheumatoid Arthritis
Status:
COMPLETED
Status Verified Date:
2010-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the utility of an electronic data capture system EDCS in a rheumatology clinical practice setting and to assess the impact of this system on patient satisfaction with patient-physician interaction
Detailed Description:
This is a randomized multicenter observational study to assess the impact of the EDCS in a rheumatology clinical practice setting on patient satisfaction with patient-physician communication using the Health Tracker electronic data capture system Patients will be randomly assigned in a 21 ratio to the Health Tracker-user or non-user groups respectively The primary outcomes of this study will be the impact that information gathered and analyzed by an electronic data capture system has on patient satisfaction with arthritis care and patient physician interactions in clinical practice Patient satisfaction will be assessed using a questionnaire developed specifically for this study
This study does not involve the use of any investigational drugs and the protocol does not mandate the treatment regimen patients will receive Physicians will prescribe antirheumatic medications in accordance with usual clinical practice The planned duration of subject participation is 12 months
This study does not involve the use of any investigational drugs and the protocol does not mandate the treatment regimen patients will receive Physicians will prescribe antirheumatic medications in accordance with usual clinical practice The planned duration of subject participation is 12 months
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None